Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Biomarkers as Drivers of Innovation in Modern Diagnostics and Therapeutics
Current Drug Targets
July 2026
Soni S.
Trajectory-Based Integration of Biomarker Dynamics and Clinical Features for Prognostic Prediction in Hepatocellular Carcinoma: A Retrospective Cohort Study
Journal of Hepatocellular Carcinoma
2026
Xu C.
Open Access
Physiopathological Features in a Three-Dimensional In Vitro Model of Hepatocellular Carcinoma: Hypoxia-Driven Oxidative Stress and ECM Remodeling
Cancers
September 2025
Rizzo M.G.
Open Access
Investigating Serum PARP2 as a Potential Diagnostic Biomarker for Hepatocellular Carcinoma
Chinese General Practice
15 November 2024
Maierhaba M.
Combined Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
Journal of Angiotherapy
2024
Tufael
Open Access
Biomarkers as prognostic and predictive factors in patients with hepatocellular carcinoma undergoing radiological oncological interventions
Klinicka Onkologie
2023
Zavadil J.
Open Access
Causal discoveries for high dimensional mixed data
Statistics in Medicine
30 October 2022
Cai Z.
Open Access
Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver Cancer
Mini Reviews in Medicinal Chemistry
2022
Zhao K.
Expression and significance of TEFM gene in hepatocellular carcinoma were analyzed based on data mining
Chinese Journal of Cancer Prevention and Treatment
28 March 2021
Han Y.
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection
Biomed Research International
2020
Chen J.
Open Access
Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis
Medicine United States
2020
Fang P.
Open Access
Serum Serotonin as a Potential Diagnostic Marker for Hepatocellular Carcinoma
Journal of Interferon and Cytokine Research
December 2019
Mamdouh F.
More than a tumor marker⋯A potential role for alpha-feto protein in inflammatory bowel disease
Inflammatory Bowel Diseases
18 June 2019
Linson E.A.
Bioinformatics analysis revealed hub genes and pathways involved in sorafenib resistance in hepatocellular carcinoma
Mathematical Biosciences and Engineering
2019
Liu J.
Open Access
Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma
Biochemical and Biophysical Research Communications
18 March 2018
Tak H.
Diagnostic value of Glypican-3 for hepatocellular carcinomas
Asian Pacific Journal of Cancer Prevention
1 March 2018
El-Saadany S.
Liver cancers
American Cancer Society S Oncology in Practice Clinical Management
16 February 2018
Ang C.
Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: A systematic review with meta-analysis
International Journal of Biological Markers
2018
Li J.
All Open Access, Green
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2
International Journal of Biochemistry and Cell Biology
August 2017
Dai W.
Variety and dynamics of proteoforms in the human proteome: Aspects of markers for hepatocellular carcinoma
Proteomes
2017
Naryzhny S.
Open Access
Knowledge and practice on magnitude, diagnosis, treatment and prevention strategies of Hepatocellular Carcinoma in Ethiopia: A Systematic review
Ethiopian Journal of Health Development
2017
Mekonnen D.
Hepatocellular carcinoma: Review of disease and tumor biomarkers
World Journal of Hepatology
2016
Kim J.U.
Open Access
The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma
Discovery Medicine
2016
Meng W.